Cross-institution positioning
May 6, 2026Mixed positioning. 1 accumulating, 2 exited across 3 comparable institutions.
Source: Schedule 13 researchHilton Worldwide Holdings Inc.
Latest stored close $326.56 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Mixed positioning. 1 accumulating, 2 exited across 3 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 3 sales by 2 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/51 non-amendment material event in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +6.5% YoY; Net income +9.5% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 52% through its reported 52-week range; +13.5% over one year.
Source: Stored historical price seriesFiled May 6, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | BEGLEY CHARLENE T | AGrant, award, or other acquisition | Common Stock | 6 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | Carr Chris | AGrant, award, or other acquisition | Common Stock | 3 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | GRAY JONATHAN | AGrant, award, or other acquisition | Common Stock | 4 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | Healey Melanie | AGrant, award, or other acquisition | Common Stock | 6 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | Mabus Raymond E | AGrant, award, or other acquisition | Common Stock | 6 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | MAYER MARISSA A | AGrant, award, or other acquisition | Common Stock | 1 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | SMITH ELIZABETH A | AGrant, award, or other acquisition | Common Stock | 9 | $0.00 | Direct | Oct 1, 2026 |
| Sep 30, 2026 | STEENLAND DOUGLAS M | AGrant, award, or other acquisition | Common Stock | 9 | $0.00 | Direct | Oct 1, 2026 |
| Sep 14, 2026 | Fuentes Laura | MExercise or conversion of derivative · derivative | Employee Stock Option (right to buy) | 4.9K | $0.00 | Direct | Sep 15, 2026 |
| Sep 14, 2026 | Fuentes Laura | MExercise or conversion of derivative · derivative | Employee Stock Option (right to buy) | 7.9K | $0.00 | Direct | Sep 15, 2026 |
| Sep 14, 2026 | Fuentes Laura | SOpen-market or private sale | Common Stock | 2.9K | $309.83 | Direct | Sep 15, 2026 |
| Sep 14, 2026 | Fuentes Laura | SOpen-market or private sale | Common Stock | 4.4K | $309.80 | Direct | Sep 15, 2026 |
| Sep 14, 2026 | Fuentes Laura | MExercise or conversion of derivative | Common Stock | 4.9K | $79.35 | Direct | Sep 15, 2026 |
| Sep 14, 2026 | Fuentes Laura | MExercise or conversion of derivative | Common Stock | 7.9K | $58.02 | Direct | Sep 15, 2026 |
| Sep 14, 2026 | Carr Chris | SOpen-market or private sale | Common Stock | 439 | $310.34 | Direct | Sep 15, 2026 |
| Aug 5, 2026 | Charnaux Christian H. | FTax/price withholding or payment | Common Stock | 1.9K | $324.56 | Direct | Aug 6, 2026 |
| Jun 30, 2026 | STEENLAND DOUGLAS M | AGrant, award, or other acquisition | Common Stock | 9 | $0.00 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | SMITH ELIZABETH A | AGrant, award, or other acquisition | Common Stock | 8 | $0.00 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | MAYER MARISSA A | AGrant, award, or other acquisition | Common Stock | 1 | $0.00 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | Mabus Raymond E | AGrant, award, or other acquisition | Common Stock | 5 | $0.00 | Direct | Jul 1, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Jul 28, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 18, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 11, 2026 | 8-K | 1.01, 2.03, 8.01, 9.01 | Material definitive agreement; New direct financial obligation; Other event; Financial statements / exhibits | Debt | Filing |
| May 5, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Apr 28, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 18, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| Feb 11, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Dec 11, 2025 | 8-K | 1.01, 1.02, 2.03, 9.01 | Material definitive agreement; Termination of material agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Dec 2, 2025 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Oct 22, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $3.3B | +6.5% |
| Ended Mar 31, 2026 | $2.9B | +9.0% |
| Ended Sep 30, 2025 | $3.1B | +8.8% |
| Ended Jun 30, 2025 | $3.1B | +6.3% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $12.0B | +7.7% |
| Ended Dec 31, 2024 | $11.2B | +9.2% |
| Ended Dec 31, 2023 | $10.2B | +16.7% |
| Ended Dec 31, 2022 | $8.8B | +51.6% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 14.9M | $326.56 | |||
| Fidelity / FMR CIK0000315066 | Mar 31, 2026 observed May 6, 2026 filed · 36d Initial Schedule 13G | Initial Schedule 13G | 11.9K | 12.00% | $304.08 | $321.51 | $326.56 |
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 17.2M | 7.49% | $304.08 | $324.07 | $326.56 |
Compare HLT with other securities showing similar institutional activity or recent accumulation across several tracked institutions.